生物活性 | |||
---|---|---|---|
描述 | Zidesamtinib (NVL-520) is an orally active, brain-penetrant inhibitor that demonstrates potent selectivity against various ROS1 fusions and resistance mutations. It exhibits IC50 values of 0.7 and 7.9 nM for wild-type ROS1 and ROS1 G2032R, respectively, while sparing TRK inhibition. Zidesamtinib serves as a valuable tool for cancer research [1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.92mL 2.38mL 1.19mL |
23.84mL 4.77mL 2.38mL |
参考文献 |
---|